Ki-67 expression in 398 cases of cutaneous melanoma and its clinical features and prognosis
李彩莉,白雪,毛丽丽,齐忠慧,盛锡楠,崔传亮,迟志宏,连斌,王轩,鄢谢桥,唐碧霞,周莉,段荣,许华艳,斯璐,郭军
DOI: https://doi.org/10.3760/cma.j.cn101548-20200701-00093
2020-01-01
Abstract:Objective:To investigate whether Ki-67 expression level has an impact on survival prognosis in patients with early stage cutaneous melanoma.Method:Peking University cancer hospital were retrospectively analyzed internal medicine treated kidney cancer melanoma patients with stage Ⅰ~Ⅲ skin melanoma, Ki-67 expression level at 25% can be divided into four groups, respectively 0(0~24%), 1(25%~49%), 2(50%~74%) and 3 (≥75%), while collecting patients clinical data, including patient age, gender, primary focal position, tumor thickness, ulceration, Clark, grading, gene mutation, eighth edition AJCC staging, LDH level and grade of ECOG, whether the adjuvant treatment of interferon, etc.) and their survival information.To analyze the correlation between different Ki-67 levels and prognosis.Results:A total of 306 patients were included in the analysis, with a median age of 48 years in the whole group and a median follow-up time of 41 months.The proportions of Ki-67 expression in 0~3 group were 53.9%, 29.4%, 14.1% and 2.6%, respectively.Relapse-free survival (RFS) was 42, 33, 18 and April (
P<0.001). The total survival time (OS) of the 4 groups was NA, 72, 35 and 19 months (
P<0.001). The expression level of Ki-67 was analyzed by multi-factor regression with 25% as the continuous variable, and
HR=1.43(95%
CI: 1.13~1.80,
P=0.002). OS
HR=1.61(95%
CI: 1.20~2.15,
P=0.001).
Conclusions:Ki-67 expression is associated with the prognosis of early cutaneous melanoma.The higher the Ki-67 expression level, the shorter the survival time and the worse the prognosis, and Ki-67 may be an independent prognostic factor for early stage skin melanoma in China.